![](/images/graphics-bg.png)
Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience
المؤلفون المشاركون
Gonzalez-Gay, Miguel A.
Calvo-Río, Vanesa
Adán, Alfredo
Blanco, Ricardo
Álvarez-Castro, Carolina
Mesquida, Marina
Calleja, Sara
Ruíz de Morales, José G.
Cordero-Coma, Miguel
المصدر
العدد
المجلد 2014، العدد 2014 (31 ديسمبر/كانون الأول 2014)، ص ص. 1-5، 5ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2014-05-28
دولة النشر
مصر
عدد الصفحات
5
التخصصات الرئيسية
الملخص EN
Objective.
To evaluate, in three Spanish tertiary referral centres, the short-term safety and efficacy of golimumab (GLM) for treatment of immune-mediated uveitis resistant to previous immunosuppressive therapy.
Methods.
Nonrandomized retrospective interventional case series.
Thirteen patients with different types of uveitis that were resistant to treatment with at least 2 previous immunosuppressors were included in this study.
All included patients were treated with GLM (50 mg every four weeks) during at least 6 months.
Clinical evaluation and treatment-related side effects were assessed at least four times in all included patients.
Results.
Eight men and 5 women (22 affected eyes) with a median age of 30 years (range 20–38) and active immune-mediated uveitides were studied.
GLM was used in combination with conventional immunosuppressors in 7 patients (53.8%).
GLM therapy achieved complete control of inflammation in 12/13 patients (92.3%) after six months of treatment.
There was a statistically significant improvement in mean BCVA (0.60 versus 0.68, P = 0.009 ) and mean 1 mm central retinal thickness (317 versus 261.2 μ, P = 0.05 ) at the six-month endpoint when compared to basal values.
No major systemic adverse effects associated with GLM therapy were observed.
Conclusions.
GLM is a new and promising therapeutic option for patients with severe and refractory uveitis.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Cordero-Coma, Miguel& Calvo-Río, Vanesa& Adán, Alfredo& Blanco, Ricardo& Álvarez-Castro, Carolina& Mesquida, Marina…[et al.]. 2014. Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience. Mediators of Inflammation،Vol. 2014, no. 2014, pp.1-5.
https://search.emarefa.net/detail/BIM-1043751
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Cordero-Coma, Miguel…[et al.]. Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience. Mediators of Inflammation No. 2014 (2014), pp.1-5.
https://search.emarefa.net/detail/BIM-1043751
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Cordero-Coma, Miguel& Calvo-Río, Vanesa& Adán, Alfredo& Blanco, Ricardo& Álvarez-Castro, Carolina& Mesquida, Marina…[et al.]. Golimumab as Rescue Therapy for Refractory Immune-Mediated Uveitis: A Three-Center Experience. Mediators of Inflammation. 2014. Vol. 2014, no. 2014, pp.1-5.
https://search.emarefa.net/detail/BIM-1043751
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1043751
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)